Stereotactic Radiosurgery for Brain Tumors

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Neuro-Oncology".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 297

Special Issue Editors

E-Mail Website
Guest Editor
Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari (APSS), 38123 Trento, Italy
Interests: radiotherapy; proton therapy; radiosurgery; brain tumors; skull base tumors

E-Mail Website
Guest Editor
Radiotherapy and Radiosurgery Department, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Milan, Italy
Interests: brain metastases; radiation therapy; radiosurgery; glioblastoma
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Radiological Sciences, Oncology and Anatomical Pathology, Division of Radiotherapy, Sapienza University of Rome, 00161 Rome, Italy
Interests: brain tumors; brain metastases; glioblastoma; radiotherapy; radiosurgery
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Stereotactic radiosurgery (SRS) is the use of a high dose of radiation, stereotactically directed to an intracranial region of interest. This allows for the non-surgical treatment of intracranial pathologies, which significantly decreases the risk of morbidity.

There are currently a number of different delivery methods for SRS, including linear accelerators, Gamma or Cyber Knife units, and charged particle methods.

Radiosurgery is currently used in the treatment of brain metastases, meningiomas, vestibular schwannomas, sellar and suprasellar lesions, and arteriovenous malformations. Moreover, SRS is widely used to treat functional conditions, such as trigeminal neuralgia and intractable tremor.

Researchers and clinicians employing SRS in daily practice are invited to submit manuscripts regarding technical as well as clinical issues.

We look forward to receiving your contributions.

Dr. Dante Amelio
Dr. Piera Navarria
Dr. Giuseppe Minniti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • stereotactic radiosurgery
  • gamma knife
  • cyber knife
  • particle therapy
  • brain tumors
  • skull base tumors

Published Papers

This special issue is now open for submission.
Back to TopTop